Purpose & when to use

Package integrity and sterility-support testing examines whether sealed packages, sterile barrier systems, and containers resist leaks or microbial ingress. Depending on the package and study objective, methods may include dye penetration, bubble emission, vacuum or pressure decay, and microbial barrier challenges. Programs align with USP <1207>, ASTM F1929, ASTM F2096, and ISO 11607 under ISO 17025 quality controls. This service is useful when package condition may affect sterility, shelf life, or change-control evidence:

  1. USP <1207> container closure integrity checks for sterile barrier systems using leak-method sensitivity, controls, and acceptance criteria.
  2. ASTM F1929 dye penetration studies for pouches, trays, or seal channels where visual leak-path evidence supports package validation.
  3. ASTM F2096 bubble emission screening for porous or flexible packages using immersion, pressure, and gross-leak observations.
  4. ISO 11607 package validation support for sterile medical packaging using integrity, microbial barrier, and aging-linked evidence.
  5. ISO 17025 change-control investigations for films, adhesives, seal settings, or suppliers using matched lots and documented fixtures.

Use package integrity and sterility-support testing when package design, the seal process, distribution stress, or a supplier change could alter barrier performance. Before samples enter testing, the method plan defines sensitivity, controls, replicates, conditioning state, acceptance criteria, and report language.

Built for sterile packaging and sealed containers

Integrity programs serve medical-device, drug-delivery, aerosol, and product-packaging teams where USP, ASTM, ISO, sterility, or quality-system expectations shape barrier evidence.

  • Sterile barriersPouches, trays, blister packs
  • Medical packagesDevice and kit packaging
  • Aerosol containersCans, valves, fitments
  • Drug deliveryPackages and delivery systems
  • Product packagesSealed consumer formats

Instrumentation & measurement ranges

We select testing platforms based on package geometry, target defect size, material compatibility, and the decision the study needs to support.

10 - 75 µmvisual

Dye penetration and ingress fixtures

Seal-channel and package-path screening with dye exposure, dwell control, rinse handling, and documented visual inspection for defects where dye methods fit the material.

0 - 30 kPapressure

Bubble emission and immersion systems

Pressurized package immersion with observation windows, pressure holds, and gross-leak records for flexible, porous, or sealed packages suited to ASTM F2096-style screening.

0 - 100 kPadecay

Vacuum and pressure decay leak checks

Fixture-based decay measurements for packages or containers where a quantitative leak signal, stable fixture seal, and package-specific acceptance criteria are available.

0 - 14 dincubation

Microbial barrier and sterility-support workflows

Challenge, incubation, and observation workflows used when package barrier performance or sterility-support evidence requires microbiological controls and defined run validity.

Test method options

MethodStrengthsTradeoffAligned with
Container closure integrity method selection
  • USP <1207> framing connects package risk, method sensitivity, acceptance criteria, and control strategy before testing starts.
  • Supports sterile barrier and container decisions where leak detection must be tied to package design and use condition.
Requires package-specific sensitivity rationale and controls before results can support sterility-risk conclusions.
USP <1207>
Dye penetration seal-channel evaluation
  • ASTM F1929 gives direct visual evidence of channels, seal voids, and edge defects in compatible porous packages.
  • Fast feedback supports seal-parameter troubleshooting across pouches, trays, films, adhesives, and supplier lots.
Applicability depends on package materials, dye visibility, seal geometry, and controlled dwell or rinse handling.
ASTM F1929
Bubble emission gross-leak screening
  • ASTM F2096 supports pressure-based gross-leak detection for flexible and porous packages that tolerate immersion.
  • Useful for rapid screening after sealing changes, distribution stress, or visible package damage.
Gross-leak screening does not replace finer leak methods when the sterility decision needs higher sensitivity.
ASTM F2096
Sterile barrier validation support
  • ISO 11607 framing links package design, sealing process, aging state, and barrier evidence for medical packaging.
  • Microbial barrier controls and post-conditioning integrity checks support validation and root-cause investigations.
Study duration and sample demand increase when aging, distribution stress, or microbial challenge legs are included.
ISO 11607

Setup configurations

A package integrity study begins with a protocol that defines the package type, seal process, lot identity, conditioning state, method sensitivity target, replicate count, positive and negative controls, and acceptance criteria. This setup ties each leak or microbial barrier result to a known package configuration and sample history, so differences among lots or conditions can be interpreted in context.

Sample matrix

Package format, material, seal width, lot, supplier, fill state, and packaging process variables documented before testing.

Device interfaces

Fixtures, adapters, seal isolation, immersion orientation, and pressure or vacuum interfaces matched to package geometry.

Environmental controls

As-received, aged, stressed, or post-shipping states defined with conditioning records and hold times.

Sample numbers

Replicates per lot, condition, and control group sized to the package-risk question and acceptance rule.

Chain of custody

Receipt, labeling, storage, conditioning, test sequence, and final disposition recorded for each package group.

Quality anchors for package barrier evidence

Before setup begins, the program needs a defined quality-system basis and a clear method framework. Together, these four anchors guide fixture design, control selection, acceptance criteria, and final report language.

  • ISO 17025AccreditedTesting-laboratory competence, traceable records, and method control.
  • USP <1207>AlignedContainer closure integrity method selection and sensitivity rationale.
  • ASTM F1929AlignedDye penetration assessment for porous package seal leaks.
  • ASTM F2096AlignedBubble emission screening for gross leaks in packages.

Key data outputs & reporting

Each package integrity and sterility-support study provides method-specific results together with the setup records needed to interpret them. The report identifies the package configuration, fixture design, conditioning state, controls, acceptance criteria, replicate results, and observed defects. When included in the scope, it also documents microbial barrier outcomes and uncertainty contributors for quantitative leak checks. Results are organized by lot, package type, condition, and method, with the measured response or pass/fail outcome clearly stated.

Primary outputs

  • Leak outcomes by package, lot, condition, and method, including pass/fail calls and quantitative decay values where applicable.
  • Defect-location notes such as seal channel, puncture, fitment, valve, flange, or tray-lid pathway when identifiable.
  • Microbial barrier or sterility-support observations, including growth/no-growth records and control validity where included.
  • Condition comparisons across as-received, aged, stressed, post-shipping, supplier, or seal-parameter groups.

Deliverables

#FormatContents
01PDF reportMethod frame, setup, controls, results, acceptance criteria, and interpretation.
02CSV / XLSX datasetsReplicate outcomes, leak values, condition metadata, and control records.
03ImagesDefect photos, dye evidence, setup views, or sample-condition documentation.

QA / QC & data integrity

Package integrity results are defensible only when package identity, controls, fixtures, and environmental history remain traceable for every condition tested. QA / QC records cover positive and negative controls, instrument checks, sample handling, conditioning logs, run-validity criteria, and acceptance criteria. That traceability is maintained from sample receipt through the final report.

Positive controls with known defects and negative controls with intact packages where the method supports them.

Instrument calibration and verification records for decay, pressure, vacuum, timing, and environmental controls.

Defined run-validity checks for dye dwell, immersion pressure, leak-rate stability, and microbial challenge controls.

Sample identity, lot, package condition, conditioning state, and chain-of-custody records for every test article.

Deviation handling for damaged samples, invalid controls, fixture leaks, excursions, and out-of-spec observations.

RESEARCH / THIS WORK IN PRACTICE

Real studies. Measured evidence.

Explore published studies connected to package integrity and sterility. Each explains the study question, approach and findings.

View related studies (1)
Packaging & Stability

Cosmetic wand-package testing: temperature and altitude

The study separated temperature-related formulation and applicator behavior from reduced-pressure leakage risk in three anonymized package variants.

Selected finding
At 40 °C, maximum losses were 93 mg, 52 mg, and 51 mg; the 93 mg result came from one anomalous unit, while the maximum among the remaining Variant A units was 46 mg.
Related context

The study addresses leakage and package behavior; this relationship does not imply that sterility was tested.

PackagingEnvironmental simulationProduct evaluation

Study-specific findings do not guarantee performance for another product.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Packaging, quality, regulatory, product-development, and manufacturing teams often need to decide which leak or barrier evidence is appropriate for a sterile barrier, container, pouch, tray, or other sealed product. The answers below cover method selection; dye penetration and bubble emission testing; microbial barrier support; connections to aging and distribution stress; sample counts; and deliverables. If the package format or regulatory framework falls outside these examples, ARE Labs can develop a different setup.

Q.Which integrity method should I use?
A.The right method depends on package material, geometry, target defect size, and decision risk. Dye penetration and bubble emission are common screening methods. Decay-style leak checks can provide quantitative evidence when suitable fixtures and defined acceptance criteria are available.
Q.Can you test packages after aging or shipping stress?
A.Yes. Packages can be tested as received, after accelerated aging, after real-time storage pulls, or after distribution stress. The report links every result to the applicable conditioning state and sample history.
Q.Do you support microbial barrier evidence?
A.Yes, when fit for purpose. The protocol defines the challenge, controls, incubation conditions, and run-validity criteria so microbial barrier observations can be interpreted alongside the integrity data.
Q.How many samples are needed?
A.The required sample count depends on package variability, the number of lots and conditions, control groups, and acceptance rules. We set the replicate plan around the package-risk question before samples are shipped.
Q.What do I receive after testing?
A.Deliverables typically include a PDF report, CSV or XLSX result tables, control records, setup notes, defect images when useful, and a discussion of acceptance criteria tied to the selected standards.